Published in Transplantation on November 01, 1980
STUDIES OF UREA EXCRETION. III: The Influence of Body Size on Urea Output. J Clin Invest (1928) 45.56
STUDIES OF UREA EXCRETION: VI. Comparison of the Blood Urea Clearance with Certain Other Measures of Renal Function. J Clin Invest (1930) 7.46
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol (1968) 3.38
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94
No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet (1998) 2.91
Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Ann Intern Med (1968) 2.72
Kidney donors live longer. Transplantation (1997) 2.61
Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58
Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol (1970) 2.53
Transplantation of porcine fetal pancreas to diabetic patients. Lancet (1994) 2.52
"Spontaneous" B cell activation due to loss of normal mouse serum suppressor. Eur J Immunol (1972) 2.38
Specific bacteriologic problems after orthotopic liver transplantation in dogs and pigs. Arch Surg (1968) 2.32
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
An everting technique for intraluminal vascular suturing. Surg Gynecol Obstet (1968) 2.12
Phase-coupling of theta-gamma EEG rhythms during short-term memory processing. Int J Psychophysiol (2002) 2.09
HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin. Lancet (1986) 2.08
Coagulation during and after orthotopic transplantation of the human liver. Arch Surg (1969) 2.03
Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet (1993) 2.00
Infections in recipients of liver homografts. N Engl J Med (1968) 1.92
Urological complications in 216 human recipients of renal transplants. Ann Surg (1970) 1.90
Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation (2000) 1.83
Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation (2005) 1.83
Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82
Hemodynamic alterations caused during orthotopic liver transplantation in humans. Surgery (1971) 1.79
Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78
Cyclophosphamide and human organ transplantation. Lancet (1971) 1.77
Cytotoxicity of human lymphocytes: antagonism between inducing processes. Nature (1968) 1.76
Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci (2000) 1.74
Metabolic effects of hepatic replacement in Wilson's disease. Transplant Proc (1973) 1.73
Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. Am J Surg (1975) 1.72
Xylene-free method for histological preparation: a multicentre evaluation. Lab Invest (2001) 1.70
Changes in serum haptoglobin and group specific component after orthotopic liver homotransplantation in humans. Proc Soc Exp Biol Med (1968) 1.68
Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes (1999) 1.65
Steroid diabetes--a sign of overtreatment with steroids in the renal graft recipient? Scand J Urol Nephrol Suppl (1980) 1.63
Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation. J Lab Clin Med (1969) 1.63
Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet (1991) 1.60
Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods (1993) 1.60
HLA and rheumatoid arthritis. A study of five families. Tissue Antigens (1981) 1.58
Surgically correctable intra-abdominal complications before and after renal homotransplantation. Ann Surg (1968) 1.56
HL-A antigens in sarcoidosis. Tissue Antigens (1973) 1.55
Plaque-formation by non-immune and x-irradiated lymphoid cells on monolayers of mouse embryo cells. Nature (1965) 1.55
Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. Clin Exp Immunol (1969) 1.53
Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study. Int J Colorectal Dis (2006) 1.53
Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol (1987) 1.52
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol (1993) 1.48
Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases. Scand J Immunol (1980) 1.46
Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther (1980) 1.39
Impaired glucose tolerance in cyclosporine-prednisolone-treated renal graft recipients. Transplantation (1988) 1.38
Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study. Lancet (1987) 1.38
SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surg Forum (1967) 1.37
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36
Autopsy findings in a long-surviving liver recipient. N Engl J Med (1973) 1.36
Resolution of hyperparathyroidism, renal osteodystrophy and metastatic calcification after renal homotransplantation. N Engl J Med (1968) 1.36
Antigen binding cells in tolerant animals. Nature (1970) 1.35
Reversible renal failure during treatment with captopril. Br Med J (1979) 1.35
Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation. Transplant Proc (1977) 1.35
Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease. Am J Hum Genet (1983) 1.33
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures. Clin Exp Immunol (1971) 1.32
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. Cell Immunol (1970) 1.31
Improvements in the preparation of heterologous antilymphocyte globulin with special reference to absorption and diethylaminoethyl cellulose batch production. Surgery (1969) 1.29
B-cell mitogenic effects on human lymphocytes of rabbit anti-human beta 2-microglobulin. Scand J Immunol (1975) 1.27
Studies of cytomegalovirus infection in renal allograft recipients. Scand J Infect Dis (1982) 1.27
Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporin. Lancet (1983) 1.26
Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scand J Infect Dis (1985) 1.25
Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg (1972) 1.24
The role of adherent cells in B and T lymphocyte activation. Immunol Rev (1978) 1.23
Drainage of thoracic duct lymph in renal transplant patients. Transplantation (1976) 1.21
Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion (1998) 1.21
HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology. Hum Immunol (1987) 1.20
Hypertriglyceridemia in renal transplant recipients treated with sirolimus. Transplant Proc (1998) 1.19
Perspectives in organ transplantation. Antibiot Chemother (1969) 1.19
Experience with human liver grafts obtained after donor cardiac standstill. Transplant Proc (1987) 1.18
Complete heart block--another HLA B27 associated disease manifestation. Tissue Antigens (1983) 1.16
Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation (1999) 1.16
CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol (1993) 1.14
B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia. Clin Exp Immunol (1978) 1.14
Quality of life in diabetic patients after combined pancreas-kidney or kidney transplantation. Diabetes (1989) 1.14
Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes (1985) 1.13
Successful outcome of segmental human pancreatic transplantation with enteric exocrine diversion after modifications in technique. Lancet (1982) 1.12
Cytotoxicity by nonimmune allogeneic lymphoid cells. Specific suppression by antibody treatment of the lymphoid cells. J Exp Med (1967) 1.12
Serum complement after orthotopic transplantation of the human liver. Clin Exp Immunol (1972) 1.12
Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology (1992) 1.12
Splenic transplantation in a case of Gaucher's disease. Lancet (1971) 1.12